Vascular Diseases (Vascular Disease)

Subscribe to Selected New Research on Vascular Diseases

7633 relevant articles (245 outcomes, 761 trials/studies) found for this Disease

Description: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.

Also Known As:

Vascular Disease; Disease, Vascular; Diseases, Vascular

Relationship Network

Disease Context: Research Results

Cardiovascular Diseases: 20552

Vascular Diseases: 7633

Hypertension: 76484

Hypotension: 15560

Myocardial Ischemia: 13523

Aneurysm: 10892

Reperfusion Injury: 9756

Vasculitis: 6757

Peripheral Vascular Diseases: 3466

Varicose Veins: 3313

Hyperemia: 3078

Angioedema: 1207

Arterial Occlusive Diseases: 1111

Varicocele: 1016

Arteriovenous Malformations: 985

Telangiectasis: 952

Diabetic Angiopathies: 947

Arteritis: 852

Compartment Syndromes: 813

Retinal Vein Occlusion: 639

Venous Insufficiency: 592

Hemorrhoids: 570

Cerebrovascular Disorders: 546

Ischemic Optic Neuropathy: 347

Hepatic Veno-Occlusive Disease: 319

Superior Vena Cava Syndrome: 311

Ischemic Colitis: 250

Angiodysplasia: 247

Aortic Diseases: 232

Angiomatosis: 177

Capillary Leak Syndrome: 176

Splenic Infarction: 123

Hemostatic Disorders: 106

Thoracic Outlet Syndrome: 86

Embolism and Thrombosis: 59

Pulmonary Veno-Occlusive Disease: 52

Vascular Neoplasms: 45

Hand-Arm Vibration Syndrome: 20

Scimitar Syndrome: 19

Spinal Cord Vascular Diseases: 10

Vascular Fistula: 4

Related Diseases

1.	Atherosclerosis (Atheroma)
2.	Stroke (Strokes)
3.	Hypertension (High Blood Pressure)
4.	Myocardial Infarction
5.	Coronary Artery Disease (Coronary Atherosclerosis)

Experts

1.	McManus, Bruce M: 6 articles (03/2005 - 11/2002)
2.	Pethig, K: 5 articles (09/2008 - 02/2000)
3.	Haverich, A: 5 articles (09/2008 - 02/2000)
4.	Gustafson, Lars: 5 articles (01/2007 - 01/2005)
5.	Algra, A: 5 articles (01/2007 - 04/2000)
6.	Mikhailidis, D P: 5 articles (01/2007 - 01/2000)
7.	Nilsson, Karin: 5 articles (01/2007 - 01/2005)
8.	Hultberg, Björn: 5 articles (01/2007 - 01/2005)
9.	Westendorp, Rudi G J: 4 articles (09/2008 - 11/2002)
10.	Wight, Thomas N: 4 articles (01/2008 - 02/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Vascular Diseases:

1.	CollagenIBA 12/01/1979 - "Treatment of the underlying collagen-vascular disease improved the eruption, while recurrence coincided with exacerbation of the systemic disease. " 07/01/2009 - "Serologic study for viral agents and collagen vascular disease were negative in all patients with renal involvements. " 04/01/2008 - "The combination of a good history and physical examination, laboratory testing, and specialized vascular laboratory studies will help detect any underlying collagen vascular disease or coagulopathy and provide physiologic-specific and patient-oriented management. " 11/01/2001 - "This study was undertaken to determine whether women with pre-existing collagen vascular disease have an increased incidence of complications after breast-conserving therapy. " 09/01/1999 - "All five patients had negative serologic studies for collagen vascular disease. " Order ALL the reference details at left...
2.	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/01/2006 - "Forty two percent of patients were regular aspirin users, and were comparable to the non aspirin group, apart from having a significantly greater prevalence of atherosclerotic vascular disease. " 01/01/2005 - "Aspirin reduces the risk of thrombotic events in a broad range of patients with vascular disease and, in selected individuals, is beneficial for primary prevention. " 10/01/1994 - "Although both high- and low-dose aspirin therapies are effective for secondary prophylaxis in patients with atherosclerotic vascular disease, the acute response to low-dose aspirin therapy is controversial. " 05/30/2009 - "Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials." 06/01/2008 - "Clinical trials demonstrated a negative impact of aspirin resistance on the clinical outcome: an about fourfold increased risk of major atherothrombotic events has been found in aspirin nonresponders suffering from vascular disease.An" Order ALL the reference details at left...
3.	HomocysteineIBA 11/01/2000 - "However, the evidence needs to be strengthened by a systematic review of all comparable studies and the demonstration, in randomised trials, that lowering total homocysteine is followed by a significant reduction in atherothrombotic vascular disease. " 10/01/2004 - "Homocysteine is a risk factor for vascular diseases, and lowering of plasma total homocysteine (tHcy) may be beneficial for health. " 05/01/2000 - "To date, no randomized clinical trial has demonstrated that lowering of homocysteine levels is beneficial in terms of reducing the prevalence of vascular disease. " 02/01/1990 - "These data show that a substantial proportion of patients with early-onset vascular disease have impaired homocysteine metabolism, which may contribute to vascular disease, and that the impaired metabolism can be improved easily and without side effects." 01/01/2008 - "These studies show that the overall risk for vascular disease is small, with prospective, longitudinal studies reporting a weaker association between homocysteine and atherothrombotic vascular disease compared to retrospective case-control and cross-sectional studies. " Order ALL the reference details at left...
4.	clopidogrel (Plavix)FDA LinkGeneric 08/15/2004 - "Clopidogrel is superior to ASA in patients with high risk of recurrence due to concomitant vascular disease or multiple risk factors. " 03/01/2002 - "These results demonstrated that long-term administration of clopidogrel was effective in preventing ischaemic events in patients with atherosclerotic vascular disease including PAD. " 05/01/2008 - "BACKGROUND: Clinical trials have helped clarify the efficacy of clopidogrel for the treatment and prevention of vascular disease. " 05/02/2007 - "Large multi-center clinical trials have indicated significant clinical benefits for patients with atherosclerotic vascular diseases receiving clopidogrel therapy. " 05/02/2007 - "Clopidogrel efficacy has been proven in cardiac and extracardiac vascular diseases. " Order ALL the reference details at left...
5.	CholesterolIBA 01/01/1998 - "Diet changes that lower fat, saturated fat, and cholesterol intake in children and adolescents can be applied safely and acceptably, resulting in improved plasma lipid profiles that, if carried into adult life have the potential to reduce atherosclerotic vascular disease." 09/01/2009 - "Therefore, the aim of this study was to investigate differences in cholesterol metabolism in relation to vascular diseases in this subset of patients. " 11/01/2007 - "We argue that evaluating the importance of cholesterol for vascular disease risk in dialysis patients can only be achieved through the eradication of confounding by randomization, and that ongoing trials of cholesterol-lowering therapy will provide a definitive answer to this question." 08/01/2007 - "The objective of this study was to compare the new International Diabetes Federation (IDF) definition and the National Cholesterol Education Program Adult Treatment Panel III (NCEP) definition and their association with cardio-vascular disease in hypertensive patients. " 04/01/2005 - "Indeed, data from several studies suggest some differences among compounds in terms of timing of action by modulation of several activating pathways which could take part either in the early, cholesterol-lowering independent, effects in the acute phase of vascular disease or during chronic treatment." Order ALL the reference details at left...
6.	Folic Acid (Vitamin M)FDA LinkGeneric 10/01/2002 - "CONCLUSIONS: Increasing natural folate intake improved folate status and decreased tHcy concentrations to an extent that may significantly reduce the risk of vascular disease. " 02/01/2004 - "The potential beneficial role of folic acid supplements on vascular disease are currently being tested in randomized placebo controlled studies." 04/09/1998 - "Further clinical trials are required to determine whether folic acid fortification may prevent vascular disease. " 08/01/2008 - "Folate status has been associated with endothelial dysfunction in adolescents with type 1 diabetes, and elevated total plasma homoocyst(e)ine (tHcy) is a risk for vascular disease in the non-diabetic population. " 11/01/2007 - "Low levels of folate have been associated with increased risk of vascular disease. " Order ALL the reference details at left...
7.	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/01/2005 - "ACE inhibitors in patients with vascular disease: should the PEACE trial change medical practice?" 02/01/2002 - "A large body of experimental evidence reporting that ACE inhibitors limit these effects has formed the rationale for major clinical trials of these drugs in the management of atherosclerotic vascular disease. " 11/21/2001 - "Recent trials of ACE inhibitors in patients with vascular disease who do not have the traditional indications for ACE inhibition have shown a reversal of endothelial dysfunction and a reduction in adverse clinical endpoints. " 06/02/2009 - "Effects of ACE inhibitors and of TZDs on vascular disease in this population are unknown. " 06/01/2009 - "Angiotensin-converting enzyme inhibitors in patients with vascular disease." Order ALL the reference details at left...
8.	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/01/2004 - "Antiplatelet agents are effective in preventing recurrence of vascular events among patients with established vascular disease or with multiple risk factors. " 10/20/2004 - "Antiplatelet agents, used alone or in combination, are effective in preventing recurrent vascular events among individuals with established vascular disease. " 01/01/1985 - "We conclude that this study should provide definitive data on the efficacy of these antiplatelet agents in preventing further vascular disease in this patient group. " 09/01/1999 - "BACKGROUND: New antiplatelet drugs are being developed and many clinical trials evaluating the benefits of antiplatelet drugs for the secondary prevention of ischemic events in patients with atherosclerotic vascular disease have been performed. " 07/01/2009 - "Antiplatelet agents (APA), key tools in the treatment of atherothrombosis, therefore became a mainstay medication for a wide range of vascular diseases. " Order ALL the reference details at left...
9.	Retinaldehyde (Retinal)IBA 09/01/2009 - "Further studies evaluating larger sample sizes are needed to confirm these results and potential adverse effects on the retinal circulation in patients with AMD and retinal vascular diseases. " 04/01/2008 - "PATIENTS AND METHODS: The clinical observational case series study included 168 eyes (from 111 patients) without retinal vascular diseases. " 10/01/2007 - "BACKGROUND: The purpose of the study was to analyse retinal vascular diseases, a frequent reason for the sudden loss of vision, with the help of duplex Doppler ultrasonography as a non-invasive procedure, and to reproduce the results known from the literature using a common clinical device, thus allowing for an inexpensive out-patient examination. " 09/01/2001 - "AIMS: The incidence of retinal, renal and cardiovascular complications and their relation to baseline risk factors was documented in this follow-up study of 10 of the 14 original centres of the WHO Multinational Study of Vascular Disease in Diabetes (WHO MSVDD). " 06/01/1999 - "The potent vasodilating effects of Ca2+ entry blockers on ocular vessels have recently been demonstrated in in vivo and in vitro studies, implying that the maintenance of ocular vascular tone relies almost exclusively on extracellular Ca2+. Ca2+ entry blockers may potentially play a role in relaxing the retinal, long posterior ciliary, and ophthalmociliary arteries to improve the ocular circulation in vascular diseases in which there is considerable vascular tone present. " Order ALL the reference details at left...
10.	Glucose (Dextrose)FDA LinkGeneric 03/27/2002 - "Improved carotid IMT after successful PTX predicts a reduction in future vascular disease events and suggests that the macrovascular disease of type 1 diabetes is at least partially reversible with improved glucose control." 03/01/2000 - "The aim of the Finnish Diabetes Prevention Study is to assess the efficacy of an intensive diet-exercise programme in preventing or delaying type 2 diabetes in individuals with impaired glucose tolerance (IGT) and to evaluate the effect of the programme on the risk factors of atherosclerotic vascular diseases and the incidence of cardiovascular events. " 03/01/2007 - "The close association between the decrease in plasma glucose concentration and the improvement in coronary vasomotor function in response to CPT suggests a direct adverse effect of raised plasma glucose concentration on diabetes-related coronary vascular disease." 10/01/2009 - "METHODS: The Hoorn study is a population-based cohort study on glucose metabolism and vascular disease initiated in 1989, with follow-up examinations in 1996-1998, 2000-2001 and 2005-2007. " 09/01/2007 - "Four main molecular mechanisms have been implicated in glucose-mediated vascular disease. " Order ALL the reference details at left...

Therapies and Procedures

1.	Transplants (Transplant) 03/11/1982 - "We hope that such transplants may ultimately provide an improved outlook for selected terminally ill patients with pulmonary vascular disease and certain other intractable cardiopulmonary disorders." 10/01/2005 - "DESIGN: This retrospective, autopsy-based study examined 27 heart transplant patients to evaluate for graft vascular disease. " 09/01/2002 - "His interest was directed to the maturation of endocardial stimulation threshold; use of non-atrial sensors in the frequent adaptation of a permanent artificial conductor of cardiac rhythm-pacemaker to load; use of continuous electrostimulation of spinal cord in patients in terminal state of vasospastic and occlusive vascular diseases; study of the effort of electromagnetic fields on pacemaker inhibition and senzation; study of biologic-synthetic grafts. " 06/01/1997 - "OBJECTIVES: To study the frequency and determinants if vascular disease in Sri Lankan patients with renal transplants. " 05/01/2009 - "OBJECTIVE: Tissue-engineered blood vessels (TEBVs) represent an innovative approach for overcoming reconstructive problems associated with extended vascular diseases by providing small-calibre vascular grafts. " Order ALL the reference details at left...
2.	Transplantation (Transplant Recipients) 01/01/1994 - "In humans, the cerebral cortex can be affected by a variety of diseases (vascular, traumatic, neurodegenerative, etc.) and, therefore, several experimental studies have been undertaken to determine to what extent transplantation of cortical neurons could prove a useful treatment for cerebral cortical damage. " 09/01/2008 - "This study was designed to address characteristics of extracoronary vascular disease in heart transplant recipients. " 04/01/2009 - "In this review, we focus on the biological feature of BMSCs, the feasibility of transplantation, the use of BMSCs in ischemic cerebral vascular disease, and the mechanism of their action." 02/01/2009 - "Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases." 09/01/2008 - "Characteristics of extracoronary vascular disease in heart transplant recipient." Order ALL the reference details at left...
3.	Amputation 02/01/2004 - "OBJECTIVE: To study the activity level and heart rate response, objectively measured during normal daily life, of persons with a unilateral transtibial amputation for vascular disease. " 08/01/2002 - "The purpose of this study was to determine the situation of patients who suffered a major amputation of the lower leg due to ischemic vascular disease, at least two years after this event. " 06/01/2001 - "STUDY AIM: The purpose of this study was to assess the quality of life following lower limb amputation for vascular disease. " 10/01/2000 - "The object of this study was to assess the 10 year outcome of patients over 70 years of age who underwent amputation for vascular diseases. " 10/01/1998 - "PURPOSE: This study was undertaken to predict rehabilitation potential and prognostic factors of patients undergoing above knee amputation for vascular diseases. " Order ALL the reference details at left...
4.	Stents 04/01/2002 - "Vascular stents have emerged as an effective treatment for occlusive vascular disease. " 01/01/2006 - "Dual-energy subtraction images are also helpful in the recognition of hilar and mediastinal masses; the detection of tracheal narrowing and vascular disease; the identification of bone, pleural, and chest wall abnormalities; and the localization of indwelling devices such as stents and catheters. " 12/05/2005 - "Other animal studies have shown that vascular stents used to relieve arterial obstruction can also be used as gene delivery systems to provide therapeutic vector constructs that can both locally prevent post stenting reobstruction, known as in-stent restenosis, and treat the underlying vascular disease. " 02/01/2005 - "With the recent advances in renal artery stent revascularization, a procedure that can be accomplished with <1% major complication rate, 90-95% success rate and 10-15% restenosis rate, multiple studies have reported the salutary hemodynamic benefits and increased awareness of prevalence of RAS in patients with vascular disease. " 05/01/2009 - "Pre-colonized polymeric vascular stents: a hope for atherosclerotic vascular disease." Order ALL the reference details at left...
5.	Lung Transplantation 12/01/1996 - "In the following years, the indications for isolated lung transplantation were enlarged by some centers with good results; this consideration, together with the scarce availability of integral heart-lung blocks, led us to use single and bilateral lung transplantation initially for parenchymal disease and subsequently also for vascular disease. " 06/01/1997 - "Lung transplantation offers the possibility of improved quality of life and survival in patients with severe pulmonary and pulmonary vascular disease. " 03/01/1994 - "Thus, improved pulmonary hemodynamics after single-lung transplantation for pulmonary vascular disease results in reversal of right heart dilatation and dysfunction, and improved myocardial performance. " 03/01/2008 - "Lung transplantation offers life-saving and life-extending treatment for children and adolescents with congenital and acquired forms of pulmonary and pulmonary vascular disease, for whom medical therapy is ineffective or insufficient for sustained response. " 11/01/2006 - "Lung transplantation is now a viable therapeutic option in the care of patients with advanced pulmonary parenchymal or pulmonary vascular disease. " Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Vascular Diseases

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 245 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>